Applications of fluorescence in situ hybridization in detection of disease biomarkers and personalized medicine
- 22 December 2017
- journal article
- review article
- Published by Springer Nature in Comparative Clinical Pathology
- Vol. 28 (1) , 3-10
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Dual-Color Fluorescence In Situ Hybridization Reveals an Association of Chromosome 8q22 but Not 8p21 Imbalance with High Grade Invasive Breast CarcinomaPLOS ONE, 2013
- Chronic lymphocytic leukemia: a clinical and molecular heterogenous diseaseCancer Genetics, 2013
- Frequent copy number gains at 1q21 and 1q32 are associated with overexpression of the ETS transcription factors ETV3 and ELF3 in breast cancer irrespective of molecular subtypesBreast Cancer Research and Treatment, 2013
- Role of Fluorescence in situ Hybridization in Lung Cancer CytologyActa Cytologica, 2012
- Detection of the enterotoxigenic genes (sei,sej) in Staphylococcus aureus isolates from bovine mastitis milk in the West Azerbaijan of IranComparative Clinical Pathology, 2012
- Development of a chromogenic in situ hybridization for Giardia duodenalis and its application in canine, feline, and porcine intestinal tissues samplesJournal of Veterinary Diagnostic Investigation, 2011
- Interleukin-6 (IL-6) serum concentrations in dogs with hepatitis and hepatic tumours compared with those with extra-hepatic inflammation and tumoursComparative Clinical Pathology, 2010
- Rapid and Accurate Diagnosis of Human Intestinal Spirochetosis by Fluorescence In Situ HybridizationJournal of Clinical Microbiology, 2009
- MTDH Activation by 8q22 Genomic Gain Promotes Chemoresistance and Metastasis of Poor-Prognosis Breast CancerCancer Cell, 2009
- 8q24 Copy number gains and expression of the c‐myc mRNA stabilizing protein CRD‐BP in primary breast carcinomasInternational Journal of Cancer, 2003